Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Eton Pharmaceutcials Inc (ETON)

Eton Pharmaceutcials Inc (ETON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 368,479
  • Shares Outstanding, K 26,818
  • Annual Sales, $ 39,010 K
  • Annual Income, $ -3,820 K
  • EBIT $ -3 M
  • EBITDA $ 0 M
  • 60-Month Beta 1.37
  • Price/Sales 10.17
  • Price/Cash Flow N/A
  • Price/Book 15.77

Options Overview Details

View History
  • Implied Volatility 84.16% ( +2.27%)
  • Historical Volatility 70.02%
  • IV Percentile 39%
  • IV Rank 14.39%
  • IV High 342.43% on 05/07/24
  • IV Low 40.73% on 10/07/24
  • Put/Call Vol Ratio 6.20
  • Today's Volume 72
  • Volume Avg (30-Day) 38
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 1,404
  • Open Int (30-Day) 1,546

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.05
  • Number of Estimates 2
  • High Estimate 0.06
  • Low Estimate 0.04
  • Prior Year -0.03
  • Growth Rate Est. (year over year) +266.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.73 +5.10%
on 03/18/25
16.26 -17.71%
on 02/28/25
-1.68 (-11.16%)
since 02/26/25
3-Month
11.61 +15.23%
on 01/08/25
18.41 -27.30%
on 02/05/25
-0.19 (-1.40%)
since 12/26/24
52-Week
3.03 +341.58%
on 04/17/24
18.41 -27.30%
on 02/05/25
+9.57 (+251.18%)
since 03/26/24

Most Recent Stories

More News
Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

ETON : 13.38 (-2.62%)
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

ETON : 13.38 (-2.62%)
Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025

ETON : 13.38 (-2.62%)
Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules

ETON : 13.38 (-2.62%)
Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600

ETON : 13.38 (-2.62%)
Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400

ETON : 13.38 (-2.62%)
New Strong Buy Stocks for January 28th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Potbelly Corporation PBPB: This franchise company has seen the Zacks Consensus Estimate for its current year earnings increasing...

PBPB : 9.41 (-0.95%)
BBCP : 5.13 (-0.77%)
NVAX : 7.39 (-2.25%)
BAK : 4.13 (+11.92%)
ETON : 13.38 (-2.62%)
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®

ETON : 13.38 (-2.62%)
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)

ETON : 13.38 (-2.62%)
Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial

ETON : 13.38 (-2.62%)

Business Summary

Eton Pharmaceuticals Inc. operates as a development stage biotechnology company. Its product pipeline consists of DS-300, EM-100, DS-100, DS-200, ET-103, ET-101, ET-102 and CT-100 which are in clinical stage. Eton Pharmaceuticals Inc. is based in Deer Park, Illinois.

See More

Key Turning Points

3rd Resistance Point 15.08
2nd Resistance Point 14.69
1st Resistance Point 14.04
Last Price 13.38
1st Support Level 13.00
2nd Support Level 12.61
3rd Support Level 11.95

See More

52-Week High 18.41
Last Price 13.38
Fibonacci 61.8% 12.53
Fibonacci 50% 10.72
Fibonacci 38.2% 8.90
52-Week Low 3.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar